SCHEMBL23809474

SCHEMBL23809474

Cc1cc(C(C)C)c2c(c1)cc(C(N)=O)n2Cc1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLA2G2A P14555 2/20 0.40
GABRA5 P31644 2/20 0.39
GABRA1 P14867 1/20 0.39
MCL1 Q07820 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
ADRA1D P25100 1/20 0.38
KMT2A Q03164 1/20 0.37
ACHE P22303 1/20 0.36
BRD4 O60885 2/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
TP53 P04637 2/20 0.35
NOX4 Q9NPH5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809353 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL23809202 0.88 KDM4E (0.47) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL26581397 0.86 KDM4E (0.47) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL26037836 0.84 TSHR (0.45) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL23809222 0.80 ALDH1A1 (0.44) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL31300585 0.80 PLA2G2A (0.47) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL26581379 0.80 BRD4 (0.47) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL23809163 0.78 ALDH1A1 (0.48) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL23809410 0.78 KDM4E (0.45) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL23809480 0.78 GPR35 (0.38) ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 ALDH1A1 2556/4885KDM4E 1156/4885HSD17B10 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.